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Recombinant protein expression has become an invaluable tool for academic and biotech-
nological projects. With the use of high-throughput screening technologies for soluble
protein production, uncountable target proteins have been produced in a soluble and
homogeneous state enabling the realization of further studies. Evaluation of hundreds
conditions requires the use of high-throughput cloning and screening methods. Here
we describe a new versatile vector suite dedicated to the expression improvement of
recombinant proteins (RP) with solubility problems. This vector suite allows the parallel
cloning of the same PCR product into the 12 different expression vectors evaluating protein
expression under different promoter strength, different fusion tags as well as different
solubility enhancer proteins. Additionally, we propose the use of a new fusion proteinwhich
appears to be a useful solubility enhancer. Above all we propose in this work an economic
and useful vector suite to fast track the solubility of different RP. We also propose a new
solubility enhancer protein that can be included in the evaluation of the expression of RP
that are insoluble in classical expression conditions.
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INTRODUCTION
Recombinant protein production has become a routine practice
in many laboratories from academic to industrial ﬁelds. Several
hosts are available for protein production among them,Escherichia
coli has been by far the most widely used. Some advantages of
this host is the low cost, infrastructure of implementation, easy
handling, high yield production, and an ever increasing set of
tools and genetic information useful for the expression of chal-
lenging targets. Despite its importance and utility, recombinant
proteins (RP) not always are produced in a soluble and homo-
geneous state. For these “difﬁcult to express” proteins, several
approaches have been developed in order to overcome the prob-
lems associated with insolubility. Some parameters that can affect
protein expression are: induction temperature, promoter strength,
use of speciﬁc E. coli strains, co-expression of molecular chap-
erones or biological partners and the use of different solubility
enhancer or fusion proteins (Correa and Oppezzo, 2011). In the
last decade, the advent of high-throughput screening methods
have facilitated the evaluation of hundreds of conditions gen-
erated from the combination of the mentioned parameters in
order to ﬁnd one that gives a soluble protein (Vincentelli et al.,
2011; Vincentelli and Romier, 2013). However, to exploit all these
variables it is necessary to have a method for cloning the target
gene in many different vectors in a fast and simple manner. Sev-
eral techniques were recently generated to facilitate the cloning
of target genes in a parallel way, in which the same insert can
be introduced into different expression vectors simultaneously.
Among these methods are the Gateway technology [Invitrogen,
(Esposito et al., 2009)], In-Fusion technology, [Clontech, (Berrow
et al., 2007)], Ligase Independent Cloning, (Aslanidis and de
Jong, 1990), and Restriction Free Cloning, [RF cloning, (Unger
et al., 2010)]. With these methodologies, the use of restriction
endonucleases is avoided, so no special sequence requirements
are necessary enabling the development of high-throughput tech-
nologies for molecular cloning (Cabrita et al., 2006; Berrow et al.,
2007; Curiel et al., 2010; Unger et al., 2010; Luna-Vargas et al.,
2011).
In thiswork,wehavemodiﬁed two commonly used commercial
vectors (pET32a and pQE80L, T7 and T5 promoters respectively)
for E. coli protein expression. We generated 12 different vectors
introducing the same sequence at the insertion site, and important
features for protein puriﬁcation like N-terminal (His)6 tag (Mur-
phy and Doyle, 2005), TEV cleavage site, and C-terminal StrepTag
II (Schmidt and Skerra, 2007), in order to set up a high-throughput
cloning and puriﬁcation protocol. The cloning strategy used for
the development of the vectors as well as for cloning the target
genes on the entire suite is based in the “RF cloning methodology”
(Unger et al., 2010). The data reported here, describe the appli-
cation of an easy methodology to clone any target in 12 different
vectors with only two primers. In order to evaluate and ﬁnd a
condition for soluble protein expression, different promoters and
solubility enhancer fusion proteins were included in these vec-
tors. Concerning protein solubility enhancers, the target gene can
be fused as a C-terminal partner with maltose binding protein
(MBP; Kapust and Waugh, 1999), thioredoxin A (Trx; LaVallie
et al., 2000), small ubiquitin-like modiﬁer protein (SUMO; Mar-
blestone et al., 2006), disulﬁde bond isomerase C (DsbC; Nozach
et al., 2013), and Histag alone in a T5 or T7 promoter context.
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Finally, we propose a new fusion protein which appears to be
an efﬁcient solubility enhancer for the RP with previous solubility
problems and is included in the vector suite. This solubility
enhancer corresponds to a truncated construct of the endoglu-
canase CelD (CelDnc) from Clostridium thermocellum. This is
a thermostable protein, highly expressed in E. coli system and
more interestingly, this molecule maintains a full activity even
in the presence of 8M Urea implying a very high stability of
its native structure (Chaffotte et al., 1992). All these character-
istics make CelDnc a good candidate to study the solubility
enhancing properties when fused a target protein. As a proof
of concept, we fused to CelDnc the decaprenylphosphoryl-β-D-
ribofuranose-2′-epimerase (DprE1) protein from Micobacterium
smegmatis (Neres et al., 2012) a difﬁcult protein to express in
E. coli (<0.4 mg/l) and we successfully improved this expres-
sion obtaining high yields of soluble and functional monomeric
protein.
In summary, here we illustrate how to generate in any labora-
tory an economic and useful vector suite to fast track the solubility
of different RP targets and we propose a new solubility enhancer
protein that can be included in the evaluation of the expression of
RP that are insoluble in classical expression conditions.
RESULTS
CONSTRUCTION OF A NEW VECTOR SUITE
Aiming to achieve a fast and economical way to evaluate the
solubility of RP, we selected two commonly used expression vec-
tors pQE-80L (Qiagen) and pET-32a (Novagen) as the starter
plasmids for the suite generation thus giving rise to T5 or T7
based vectors. In order to provide a parallel cloning of the target
gene and an easy protein puriﬁcation method, all the generated
vectors contain the same insertion site and antibiotic resistance
(ampicillin), an N-terminus His-Tag with the tobacco etch virus
(TEV) recognition site and a C-terminus strep-Tag II (Figure 1;
Table 1). In addition, we introduced several solubility enhanc-
ing proteins including MBP, Trx, DsbC, SUMO, and CelDnc, in
combination with the two promoters (T5 or T7). An extra ser-
ine residue was added after the TEV site to decrease steric effects
and improve cleavage. This can be avoided by not including it in
the forward primer. This extra codon also generates a BamHI
site at the beginning of the gene so it can be useful for anal-
ysis of clones or to do a restriction based method if preferred
(Figure 1).
VALIDATION OF THE NEW VECTOR SUITE
In order to evaluate the expression capabilities and functionality of
this new vector suite we selected green ﬂuorescent protein (GFP)
as control protein and two “difﬁcult to express” RP such as DprE1
and the MAP kinase 4 from Leishmania major (MPK4). All of
them were cloned into 12 different vectors and their expression
was evaluated. The results showed that all the GFP constructs were
produced soluble and at the expected molecular weight. Fractions
treated with TEV showed the correct cleavage and release of GFP
protein and fusion partner (Figure 2A). The construct DsbC-GFP
under the control of T7 promoter was the less productive when
working at 37◦C. This was over-passed when the expression was
done at 17◦C over night (ON) where an increment of cleaved
proteins was obtained in most of the cases (Figure 2A).
For the case of DprE1 constructs, we can see that despite a
correct growth and induction conditions in the culture, it was
not possible to obtain any expression of this RP when fused only
to a Histag. In contrast, fusion of DprE1 with MBP, Sumo, Trx,
and CelDnc give a good soluble production and only low yields
account for the DsbC/DprE1 construct (Figure 2B; Table 2). Also,
there was an effect of the induction temperature and promoter
strength in protein expression where DprE1 was expressed with
higher yields at 37◦C compared to 17◦C and with the T5 pro-
moter compared with T7 for most of the cases. Interestingly, our
results suggested that DprE1 fused with CelDnc (in the condition
T5-37◦C) appear to be one of the most overexpressed fused pro-
teins. For the case of DprE1/CelDnc in T7 at 17◦C, there was no
cell growth. Finally, the treatment with TEV revealed that DprE1
FIGURE 1 | Schematic representation of vector suite.The generic module
with the different characteristics is shown. T5/T7, promoter type; AmpR, ampi-
cillin resistance; tobacco etch virus protease recognition site (TEV), 6xHis, His-
Tag; Sumo, Trx, DsbC, MBP, and CelDnc are the different fusion proteins.
The generic sequences to add to the forward and reverse primers are indicated,
italic letters correspond to the BamHI restriction site. * represent a stop codon.
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Table 1 | Primer list for vector generation, cloning, and sequencing.
Primer Sequence 5’–3’ Characteristics
CelDwtNFor GGATCGGAAAACCTGTATTTTCAGGGATCCATGACCATGATTACGAATTCCCGG Cloning of CelDwt
CelDwtCRev GCTGCAGGTCGACGCCAAGATCCTTTTTTATATTGGTAATTTCTCGATTACCCT
CelDtruncNFor GGATCGGAAAACCTGTATTTTCAGGGATCCTCGGGATTGATTGAGACCAAAGTG Cloning of CelDnc
CelDtruncCRev GCTGCAGGTCGACGCCAAGATCCTTTTTTAAGCAGAATTATAGTTGACAAATCCGG
QE3790For GGATCGGAAAACCTGTATTTTCAGGGATCCATGGGCGCGGTACCCTCACTGACG Cloning of Rv3790
QE3790Rev GCTGCAGGTCGACGCCAAGATCCTTTTTTAGAGCAGTTGCAGGCGCCTGGCCATG
CelDInsFor ATGAGAGGATCGCATCACCATCACCATCACGGATCTTCGGGATTGATTGAGACCAAAGTGTC Insertion of CelDnc as a fusion partner
CelDInsRev GGATCCCTGAAAATACAGGTTTTCCGATCCGCTACCAGCAGAATTATAGTTGACAAATC
strepCterFor TCCGACATGGCCAGGCGCCTGCAACTGCTCGGATCCGGCAGCTGGAGCCACCCGCAGTTC Insterion of a C-terminus strepTagII
strepCterRev TGGCTGCAGGTCGACGCCAAGATCCTTTTTTACTTTTCGAACTGCGGGTGGCTCCAGCTG
SumoFor CATCACCATCACCATCACGGATCTTCGGGAATGTCGGACTCAGAAGTCAATCAAG Insertion of Sumo as a fusion partner
SumoRev CTGAAAATACAGGTTTTCCGATCCGCTACCATACGTAGCACCACCAATCTGTTC
TrxFor CATCACCATCACCATCACGGATCTTCGGGAATGAGCGATAAAATTATTCACCTG Insertion of TrxA as a fusion partner
TrxRev CTGAAAATACAGGTTTTCCGATCCGCTACCGGCCAGGTTAGCGTCGAGGAACTC
MBPFor CATCACCATCACCATCACGGATCTTCGGGAATGAAAACTGAAGAAGGTAAACTG Insertion of MBP as a fusion partner
MBPRev CTGAAAATACAGGTTTTCCGATCCGCTACCATTAGTCTGCGCGTCTTTCAGGGC
DsbCFor CATCACCATCACCATCACGGATCTTCGGGAGATGACGCGGCAATTCAACAAACGTTAGCC Insertion of DsbC as a fusion partner
DsbCRev CTGAAAATACAGGTTTTCCGATCCGCTACCTTTACCGCTGGTCATTTTTTGGTGTTCGTC
T5T7For TTTGTTTAACTTTAAGAAGGAGATATACATATGAGAGGATCGCATCACCATCACCATCAC Transfer of the entire cassette to pET32a
vector
T5T7Rev CAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCTTGGCTGCAGGTCGACGC
GFPFor GGATCGGAAAACCTGTATTTTCAGGGATCCAGCAAAGGAGGAGAACTTTTC GFP cloning
GFPRev GAACTGCGGGTGGCTCCAGCTGCCGGATCCTCAAAGCTTTTTGTAGAGCTCATC
MPK4For GGATCGGAAAACCTGTATTTTCAGGGATCCATGGCTCAACTCGTCCCTTTAGC MPK4 cloning
MPK4Rev GAACTGCGGGTGGCTCCAGCTGCCGGATCCCTATTCGTTCAATTGTGAATGGG
MBPSeqFor CGCTGGCGCGAAAGCGGGTC MBP sequencing
CelDSeqFor GTGCCCTGGAGCAGTGCCGC CelD sequencing
RP fused with all these enhancers remains in a soluble state con-
ﬁrming an important improvement expression after usage of this
vector suite (Figure 2B).
Concerning MPK4 our results showed that of the 12 constructs
only 2 gave a band at the expected molecular weight. These cor-
respond to the construct pT7-DsbC-MPK4 and pT7-MBP-MPK4
(Figure 2C). In both cases TEV protease was able to cleave the
fusion but only in the pT7-DsbC-MPK4 constructs it was possible
to get a soluble protein after cleavage (Figure 2C, TEV treatment
section). In order to conﬁrm this result and validate our suite
vector we proceed to perform a large scale puriﬁcation with this
construct. Our results showed that after protein puriﬁcation by
IMAC it is possible to obtain the DsbC-MPK4 fusion in a solu-
ble manner and with a yield of 6 mg/l (Figure 2D). Oligomeric
state analysis of the DsbC-MPK4 fusion, revealed that the eluted
peak is maintained as a soluble decameric oligomer with an appar-
ent molecular weight of around 650 kDa (Figure 2D). This result
was veriﬁed by dynamic light scattering (data not shown). Despite
the fact, a great part of the MPK4 protein precipitate after TEV
treatment, an interesting and scalable amount of this protein
remains in a soluble form (Figure 2D).
Altogether these results, underline the importance of this new
vector suite as an improved tool for the soluble expression of
DprE1 and MPK4 proteins and suggest that it can be very valuable
for the expression of other “difﬁcult to express” RP.
USE OF ENDOGLUCONASE D VARIANT (CelDnc) FOR THE SOLUBLE
EXPRESSION OF DprE1 PROTEIN
After expressing the new construct (CelDnc), we found out that it
is expressed at high yields (>400mg/l) in a solublemonomeric and
functional form which in turn maintains thermostable character-
istics as the entire version (Figures 3A,B). So, we wondered if this
extreme solubility and stability could help in the production and
folding of other target proteins. In this regard, we fused CelDnc
to the N-terminus of the protein DprE1. The results showed that
the fusion was successfully produced in a soluble manner and that
after TEV treatment and gel ﬁltration puriﬁcation it remains sol-
uble, monomeric and it was able to retain a FAD binding property
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FIGURE 2 | Protein production screening in the vector suite. Panels (A,B)
corresponds to the E-PAGE 96 acrylamide gels for the expression screening
of GFP and DprE1, respectively. The incubation with TEV protease for fusion
cleavage is indicated with a +sign over the corresponding lines. Cleaved
target protein at the expected molecular weight (MW) is depicted.
Additionally, induction temperatures are indicated over each panel. (C)
Expression screening for MPK4 at 17◦C using a Labchip GX II (Caliper, USA)
microﬂuidic detection system. Arrows indicate the presence of a band with
the expected molecular weight. Construct names are provided over each gel
line. Solubility improvement with vector suite is indicated by arrows. (D)
Analytical size exclusion chromatography (SEC) of the IMAC puriﬁed fraction
of DsbC-MPK4. Peaks at 7.6 and 8.4 ml correspond to the exclusion volume
and the 600 kDa decameric form of DsbC-MPK4, respectively. The 12%
SDS-PAGE shows the fusion protein obtained by IMAC puriﬁcation and
DsbC-MPK4 digested byTEV protease. The expected molecular weight of
MPK4 (41.7 kDa) is indicated by an arrow.
Table 2 | Expression screening of DprE1 protein.
Construct name Fusion protein MW DprE1 fusions (kDa) Yield at 37◦C (mg/l) Yield at 17◦C (mg/l)
T5 promoter
pT5-DprE1 Only HisTag 53.7 0.4 0.2
pT5-Sumo-DprE1 Sumo 65.5 12.3 14.1
pT5-Trx-DprE1 Trx 65.8 14.8 10.4
pT5-DsbC-DprE1 DsbC 77.4 6.2 4.7
pT5-MBP-DprE1 MBP 94.3 15.4 11.3
pT5-CelD-DprE1 CelDnc 114.8 19.5 12.8
T7 promoter
pT7-DprE1 Only HisTag 53.7 0.1 0.2
pT7-Sumo-DprE1 Sumo 65.5 11.6 10.1
pT7-Trx-DprE1 Trx 65.8 12.4 9.8
pT7-DsbC-DprE1 DsbC 77.4 8.1 3.9
pT7-MBP-DprE1 MBP 94.3 12.8 15.8
pT7-CelD-DprE1 CelDnc 114.8 19.2 ND
After puriﬁcation by IMAC, concentration of the entire fusions and yield was determined at 280 nm taking into account the different extinction coefﬁcients. The
expected molecular weight as well as construct name and characteristics are indicated.
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FIGURE 3 | Continued
FIGURE 3 | Continued
(A) Analysis of the purity and monomeric states of CelDwt (gray) and
CelDnc (black). SEC was performed in a Superdex 200 16/60 and protein
purity evaluated in a 10% SDS-PAGE. (B) Differential scanning calorimetry
(DSC) curves of CelDwt (top panel) and CelDnc (bottom panel). Determined
melting temperature (Tm) is indicated for each case. (C) Large scale
expression and puriﬁcation of DprE1. DprE1 was fused to CelD, expressed,
and puriﬁed by IMAC. After TEV cleavage and second IMAC puriﬁcation, the
monomeric state was conﬁrmed by SEC in a Superdex 200 16/60. FAD
binding properties of DprE1 are conﬁrmed by peaks at 360 nm (red) and
460 nm (pink). Purity of DprE1 (53.7 kDa) was evaluated by 12% SDS-PAGE.
CelDnc (61.1 kDa) was added as a control. Arrows indicates the retention
volume for BSA (66.5 kDa).
as expected for this protein (peaks at 360 and 460 nm; Figure 3C).
The ﬁnal yield was of 7 mg/l which corresponds to more than 17
times improvement in soluble protein expression when compared
with no fusion (<0.4 mg/l). Moreover, the same experiment done
with MBP fusion resulted in a ﬁnal yield for DprE1 of 2.8 mg/l
(data not shown), demonstrating the usefulness of CelDnc as a
solubility enhancer of RP.
These results suggest that the construct CelDnc is an interesting
new solubility enhancer that could be taken into account for the
expression screening of “difﬁcult to express” RP.
DISCUSSION
Puriﬁed and soluble proteins are essential tools in academic, indus-
trial and medical areas. The knowledge of the molecular structure
of individual proteins allow addressing important questions about
the physiological function of these molecules, so as to know the
biochemical and regulatory pathways inwhich they are implicated.
However, a common scenario is that the ﬁrst attempt for obtain-
ing soluble protein often fails, requiring the optimization of many
parameters increasing production costs and time. One of the stan-
dard procedures to circumvent this problem is to screen a series
of constructs to identify the optimal vector and culture conditions
able to produce enough soluble protein. This may also include the
expression of the full-length protein, mutated and/or truncated
variants, as well as speciﬁc domains of RP (Dahlroth et al., 2006;
Yumerefendi et al., 2010). Series of fusion partners may also be
investigated for their effects on driving enhanced expression or
their capacity to capture and purify the target protein quickly with
minimal impurities (Young et al., 2012).
In this work, we describe the generation of a vector suite com-
posed of 12 different expression vectors using the RF cloning
method. This suite engages the expression of the RP with strong
promoters such as T7 or T5, with N-terminus His-tag, a TEV
speciﬁc cleavage site and a C-terminus StrepTag II as well as differ-
ent fusion proteins such as Sumo, Trx, DsbC, MBP, and CelDnc.
All these vectors contain the same site of insertion in order to
enable a parallel cloning for solubility screening and the posterior
large scale puriﬁcation in a simple and general manner (IMAC
puriﬁcation, TEV cleavage and dialysis, 2nd IMAC). The suite is
based on the commonly used pET and pQE vectors and presents
no major changes in expression or sequencing protocols. The
cloning strategy occurs in an insert-sequence independent man-
ner, with the additional advantage that no restriction site or extra
aminoacids are added to the N-terminus of the expressed pro-
tein after TEV cleavage, apart from the last glycine residue. As
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puriﬁcation features we selected the use of the HisTag, because
it has demonstrated to be very versatile, cheap and to work
well in small and large scale puriﬁcations (Schafer et al., 2002;
Steen et al., 2006). Additionally, if the stop codon of the target
gene is omitted, an additional puriﬁcation tag, the strepTag II is
expressed in the C-terminus of the target protein. This last can
be useful if degradation intermediates appear by coupling IMAC
puriﬁcation with StrepTacting puriﬁcation only a product with
an intact N- and C-terminus will be puriﬁed. Also the puriﬁ-
cation via the StrepTag II showed to be very useful for proteins
that are expressed in low abundance where usually puriﬁcation
by IMAC gives many contaminants from the host (Magnusdottir
et al., 2009). Finally the TEV site was chosen for protein cleav-
age as it has demonstrated to be very speciﬁc, work well at low
temperatures and can be produced in the laboratory with high
yield reducing production costs (van den Berg et al., 2006). More-
over, it was shown that the last residue of the cleavage site (Gly)
can be changed for all the other residues except for proline for
an expense in cleavage efﬁciency, so if a protein with a native N
terminus is needed it can be taken into account (Kapust et al.,
2002).
The suite was tested with GFP, and we found out that in all
cases there were expression and cleavage with TEV demonstrating
that all the vectors worked well. By using this suite of vectors the
high-throughput screening for soluble expression could be easily
achieved manually or automatically as it was demonstrated for the
expression of GFP, DprE1 and MPK4.
In order to challenge the vector suite proposed here we selected
two “difﬁcult to express” RP like DprE1, and MPK4. For the ﬁrst
protein evaluated (DprE1) the vector suite demonstrated that the
expression protein improved when the target protein was fused to
Sumo, Trx, DsbC, MBP, and CelDnc solubility enhancer proteins.
Among them the best results concerning solubility and quantities
of stable protein was achieved when DprE1 was fused to CelDnc
and subsequently cleaved by TEV. In the second case, only two out
of 12 conditions evaluated were able to express MPK4 in the sol-
uble fraction and only one (pT7-DsbC-MPK4 construct) remains
soluble after TEV cleavage. Interestingly, high yield of this fusion
construct remained as a decamer before TEV cleavage, so after
improving puriﬁcation protocols (like the use of strepTag II or
ion exchange chromatography), the entire fusion can be used for
crystallization screenings.
Despite the fact that, many fusion proteins were evaluated, it
remains difﬁcult to deﬁne a “universal fusion protein.” Differ-
ent options are commercially available (MBP, GST, Trx, DsbC,
NusA, etc), and several groups have found new proteins that can
be promising alternatives to obtain a soluble and homogeneous
recombinant protein (Chatterjee and Esposito, 2006; DelProposto
et al., 2009; Cheng et al., 2010; Song et al., 2011) by fusing the target
gene. In this work, we evaluated the use of a novel fusion protein,
CelDnc that is thermostable (Tm: 71.4◦C) and is expressed inmas-
sive amounts in E coli system. CelD is an endo-β-glucanase (EC
3.2.1.4) from C. thermocellum and is part of the cellulose degrad-
ing complex termed cellulosome composed of a large number of
individual enzymes (Kataeva et al., 1997).
When this protein was evaluated as a solubility fusion enhancer
for DprE1 the results showed an increasing solubility performance
for this molecule compared with other classical fusion enhancers
like MBP. After expression and IMAC puriﬁcation was done the
CelDnc fusionwas soluble in large amounts. Moreover,DprE1was
still soluble, monomeric and presented FAD binding properties
even after the proteolitical removal of CelDnc demonstrating the
utility of this fusion protein that can be taken into account when
solubility screening is performed.
In this work we propose a new vector suite and a new fusion
enhancer molecule with chances to improve the solubility of dif-
ferent RP. The vector suite proposed here allows the evaluation of
ﬁve different fusion proteins or only the HisTag in combination
with two different promoters, giving rise to 12 different constructs
for a single target gene. Altogether, our results suggest that this
expression systemcouldbe an interesting tool to improve solubility
problems of RP.
Moreover, the screening protocol can be further improved. In
the present work we used Rosetta cells for the screening of RP
production. Different E. coli strains can be evaluated in parallel
like the use of strains for disulﬁde bond formation (Shufﬂe, New
Engalnd Biolabs), reduced mRNA degradation (BL21 Star, Invit-
rogen) among others. Also, the co-expression of chaperones or
molecular partners can be included if they are in a vector compat-
ible with a ColE1 replication origin. By the complementation of
such variables with the vector suite, a great number of conditions
can be screened, increasing the chances of ﬁnding the optimal
context for target protein production.
It was shown that the sequence at the translation initiation
region (TIR) can have a detrimental effect in protein production
due to the generation of secondary structures in the messenger
RNA that can hamper the translation by the ribosome complex.
In this regard a predictive method was developed for designing
synthetic ribosome binding sites (RBS) that can minimize the
formation of secondary structures at RNA level, so increasing
the translation rate (Salis et al., 2009; Salis, 2011). Because the
nucleotide sequence from +1 to +25 is the same in all vectors,
a new RBS can be designed and introduced into the entire suite
increasing translation rates.
Finally, despite the cloning of target genes into the suite was
very efﬁcient, false positives were found in some cases. This
can be improved, for example, if a toxic gene like the toxin
CcdB of type II toxin-antitoxin system is added at the insertion
site.
Despite the fact that, more proteins should be tested in this
vector suite and that there is no magic formula able to ensure the
solubility of different proteins, this could be a useful and economic
model to fast track the soluble expression of the RP.
MATERIALS AND METHODS
GENERATION OF THE VECTOR SUITE
For the generation of the vector suite we used amodiﬁed version of
the pQE80L (Qiagen) as the starter plasmid, that contained a TEV
cleavage site after the Histag separated by a GSGS linker (pQE80L-
TEV). In a ﬁrst step we cloned the gene DprE1 into this vector and
added the different modules for the vector suite (linkers, strepTag
and different fusion proteins) thus generating the T5 series. Then
the entire constructs were cloned into the vector pET32a in order
to generate the T7 series.
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All PCR were done using Phusion polymerase (Finnzymes).
For the ampliﬁcation of the fragments (megaprimer generation)
conditions were 30 s at 98◦C and 28 cycles of 98◦C for 10 s, 59◦C
for 1 min and 72◦C for 1 min with a ﬁnal extension step at 72◦C
for 5 min and PCR products were puriﬁed by agarose gel. The
generatedmegaprimers contained 30 bp in both ends that overlaps
with the insertion site in the destination vectors. The integration
into the vectors was done by RF cloning (Unger et al., 2010) and
the RF reaction was as follows: 30 s at 98◦C and 30 cycles of 98◦C
for 10 s, 60◦C for 1 min and 72◦C for 5 min with a ﬁnal extension
step at 72◦C for 7 min. For RF reactions 120 ng of megaprimers
and 30 ng destination vector were used. 20 μl were digested with
2 μl Fast Digest DpnI (Thermo) for 15 min at 37◦C in order to
remove parental plasmid, and 5 μl were used to transform 50 μl
of competent DH5α E. coli cells. Positive clones were conﬁrmed
by colony PCR by using Taq polymerase (Invitrogen) with the
same primers used for megaprimer generation. Colony PCR was
as follows, 95◦C for 3 min, 25 cycles of 95◦C for 30 s, 60◦C for 30 s
and 72◦C for 2 min followed by a ﬁnal extension step at 72◦C for
5 min. Positive colonies were selected for plasmid extraction and
conﬁrmed by sequencing.
The gene for DprE1 was ampliﬁed from M. smegmatis genomic
DNA using the primers QE3790For and QE3790Rev for the
generation of the megaprimer (Table 1). The product was
cloned into the vector pQE80L-TEV by RF cloning to gener-
ate the construct pDprE1. The genes coding for CelDwt or
the truncated version CelDnc (residues 32–577), were ampli-
ﬁed from the plasmid pCT603 (Chaffotte et al., 1992) with the
primers CelDwtNFor and CelDwtCRev for CelDwt and primers
CelDtruncNFor and CelDtruncCRev for CelDnc (Table 1) and
cloned by RF in the same vector to generate the constructs pCelD
and pCelDnc. The construct pDprE1 was used for the inser-
tion of CelDnc in the 5′ of DprE1 (between the HisTag and
the GSGS linker, Figure 1). CelDnc was ampliﬁed from the
pCelDnc construct using primers CelDInsFor and CelDInsRev.
The forward primer was designed also to add a GSSG linker
to separate the HisTag from the fusion partner generating the
construct pCelD-DprE1. The generated constructs (pDprE1 and
pCelD-DprE1) were then used to add the last module of the vec-
tor, the C-terminal strepTag II. The strepTag II was inserted at
the C-terminus separated by a GSGS linker with primers strepC-
terFor and strepCterRev (Table 1) for the generation of the
vector pT5-DprE1 (HisTag alone) and pT5-CelD-DprE1 (CelDnc
fusion). The primers anneal each other, so they were used with-
out addition of DNA for the generation of the megaprimer. The
generated pT5-CelD-DprE1 vector was then used for the inser-
tion and replacement of CelDnc by other fusion partners. In
this regard the primers SumoFor and SumoRev; TrxFor, and
TrxRev; MBPFor and MBPRev and DsbCFor and DsbCRev were
used for the insertion of Sumo, TrxA, MBP, and DsbC, respec-
tively, (Table 1). The genes were ampliﬁed from Saccharomyces
cerevisiae for Sumo, pET32a (Novagen) for TrxA, pMAL (New
England Biolabs) for MBP; and E. coli genome for DsbC. By
this way, the T5 vector series was completed. All 6 vectors were
conﬁrmed by sequencing with the QEFor and QERev plasmid
primers. For the case of MBP and CelDnc constructs internal
primers were also used in order to cover the entire sequence.
The last step was to transfer the modules into a T7 context.
To do this, we selected the pET32a (Novagen) as a destination
vectoramplifying the entire cassette from T5 series (from MRGS-
HisTag up to the strepTag II for the different fusions) with the
primers T5T7For and T5T7Rev and replacing the expression cas-
sette of the pET32a vector. The generated megaprimers were
used for the RF reactions. By this way the vector suite was com-
pleted containing the gene DprE1 in all 12 vectors for expression
screening.
CLONING OF GFP AND MPK4 INTO THE SUITE OF VECTORS
Leishmania major MPK4 gene was ampliﬁed with primers
MPK4For andMPK4Rev from a pGem vector containing the gene.
GFP was ampliﬁed with primers GFPFor and GFPRev from a pET
vector containing a GFP variant that is well expressed in E. coli
(Waldo et al., 1999).
The 12 vectors were added to 12 different PCR tubes, and the
ampliﬁed products were used as megaprimers for the RF reaction
using the HF buffer from Phusion polymerase. After digestion of
20 μl PCR products with 2 μl DpnI, chemical competent cells
were transformed with 5 μl RF reaction in a PCR machine with
the following program: 30 min at 4◦C, 45 s at 42◦C, 3 min at 4◦C,
addition of 100 μl of LB, 1 h at 37◦C, and plating of 100 μl in
agar plates containing ampicillin. Four colonies for each construct
were selected and conﬁrmed by colony PCR and sequenced. After
the analysis we found out that in most cases all were positive (or
at least three of four were positive) giving a percentage of success
of more than 80%.
EXPRESSION SCREENING OF GFP AND DprE1
Chemocompetent Rosetta-pLysS cells were transformed with
5 μl of puriﬁed plasmids as described above and then incu-
bated in a shaker ON at 37◦C in 1 ml of LB with chloram-
phenicol and ampicillin in a 96 × deep-well plate. 100 μl of
ON culture were used to inoculate 4 ml of Terriﬁc Broth in
24 × deep-well plates by duplicate. Cultures were incubated at
37◦C until D.O.600 reached 1.0–1.2. At that moment one plate
was induced with 1 mM IPTG and left at 37◦C for 4 h. The
other 24 deep-well was incubated at 17◦C for 15 min to cool-
ing it and then induced with 1 mM IPTG ON at the same
temperature. After induction time was reached, cells were har-
vested, resuspended in 1 ml lysis buffer (50 mM Tris pH 8.0;
300 mM NaCl, 10 mM imidazol, 0.5 mg/ml lysozyme) and
frozen at −80◦C. After thawing cells, 10 units of DNase I and
10 μl of 2M MgSO4 were added and incubated with shaking
for 20 min at 20◦C. Then 200 μl of Nickel beads (Qiagen)
equilibrated in binding buffer (50 mM Tris pH 8.0; 300 mM
NaCl, 10 mM imidazol) were added to cell extracts and incu-
bated for 15 min at 20◦C. Cell extracts were then transferred
to a 96×-well ﬁlter plate assembled in a vacuum device, and
bound protein was washed with 2 ml of binding buffer. An
additional wash step was done with 2 ml of binding buffer
containing 50 mM imidazol. Elution was done with 160 μl of
elution buffer [50 mM Tris pH 8.0; 300 mM NaCl, 500 mM
imidazol; for a detailed protocol, see (Saez and Vincentelli,
2013)]. Eluates were divided in two groups for evaluation of
uncleaved protein and assessment of TEV cleavage ON at 18◦C.
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Samples were then loaded into an E-PAGE 96 acrylamide gel
(Invitrogen).
EXPRESSION SCREENING OF MPK4
Expression screening and puriﬁcation of MPK4 constructs was
made in a similar way than for GFP and DprE1 but only 17◦C of
induction was evaluated. Puriﬁcation steps were the same but the
pipeting scheme was done automatically by using a TECAN Free-
dom EVO®200. Expression analysis was done also automatically
by using a Labchip GX II (Caliper, USA) microﬂuidic detection
system.
LARGE SCALE EXPRESSION AND PURIFICATION OF DsbC-MPK4
DsbC-MPK4 was expressed in Terriﬁc Broth (TB) supplemented
with ampicillin and chloramphenicol and induction was done at
D.O600: 1.2ONat 17◦Cwith 1mMIPTG. Pellets were resuspended
in lysis buffer and frozen at −80◦C. After thawing, the pellets were
sonicated and centrifugated at 15.000 × g. Soluble fraction was
injected in a 1 ml IMAC column (GE Healthcare) equilibrated in
binding buffer. Elution was done in a linear gradient of 5–100% B
in 10 column volumes (CV) with elution buffer. Puriﬁed protein
was cleaved with TEV protease in a 1:30 protein:enzyme ratio and
dialyzed against cleavagebuffer (50mMTris pH8.0; 150mMNaCl,
1 mM DTT) ON at 8◦C. Sample was ﬁltered through 0.22 μm to
remove precipitates, and analyzed by SDS-PAGE.
EXPRESSION AND PURIFICATION OF CelD AND CelDnc
Production of CelD and CelDnc was done in M15pREP4 from the
constructs pCelD and pCelDnc, respectively, in 1 l 2YT supple-
mented with ampicillin and kanamycin, and induced with 1 mM
IPTG at D.O. 1.0 ON at 37◦C. IMAC was done like for the case of
DsbC-MPK4 but using a 5 ml column and only half of the soluble
fraction was used. TEV cleavage was done as before and desalted in
order to remove imidazole. The reaction was injected in a second
IMAC under same conditions as above and the ﬂow through con-
taining the cleaved protein was injected in a Superdex 200 16/60
(GE Healthcare) equilibrated with buffer 40 mM Tris pH 7.7.
DSC ANALYSIS OF CelD AND CelDnc
Differential scanning calorimetry (DSC) experiments were carried
out in PBS, in a VP-DSC instrument (Microcal, Northampton,
MA, USA) and data analyzed with the software supplied with the
equipment. The temperature was increased at 1◦C per minute
from 30 to 80◦C, and proteins were added at concentration of
1 mg/ml for CelD and CelDnc.
LARGE SCALE EXPRESSION AND PURIFICATION OF pT5-DprE1,
pT5-CelD-DprE1 AND pT5-MBP-DprE1
Inductionof p5DprE1, p5CelDnc-DprE1 andp5MBP-DprE1were
done inM15pREP4with 1mMIPTG in 1 l 2YT supplementedwith
ampicillin (100 μg/ml), kanamycin (50 μg/ml) and 15 μM FAD at
D.O.: 1.0–1.2 during 4h at 37◦C.Cellswereharvested, resuspended
in lysis buffer and frozen at −80◦C. After thawing the cells, were
lysed and protein puriﬁed as before. Puriﬁed protein was cleaved
with TEV in a 1:30 ratio, and dialysed against cleavage buffer. The
product was then puriﬁed by a second IMAC and injected in a
Superdex 200 16/60 equilibrated with buffer 25 mM Tris pH 8.0;
150 mM NaCl.
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